Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells. - Wikidata - wikimedia - TriplyDB

Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.

Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.

http://www.wikidata.org/entity/Q34502573

about

The potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivo Safety of Nanoparticles in Medicine Detection and Physicochemical Characterization of Membrane Vesicles (MVs) of Lactobacillus reuteri DSM 17938 The nano-plasma interface: Implications of the protein corona.Helicobacter pylori ATCC 43629/NCTC 11639 Outer Membrane Vesicles (OMVs) from Biofilm and Planktonic Phase Associated with Extracellular DNA (eDNA).Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies.Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment.Proteomic Profiling of a Biomimetic Drug Delivery Platform.Compounds From Celastraceae Targeting Cancer Pathways and Their Potential Application in Head and Neck Squamous Cell Carcinoma: A Review.Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells.A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery.Contribution of Kupffer cells to liposome accumulation in the liver.Identification of Triptophenolide from Tripterygium wilfordii as a Pan-antagonist of Androgen Receptor.A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F.

P2860

Q26827175-D02A3018-8D5C-4520-9E82-C4568A9C4712 Q28083076-D3FB5723-605C-4AFC-9BF5-6038B9C1EE28 Q33790220-54A5FEB1-218B-4638-BD25-C429A9C09D97 Q34122883-899E2021-A5D7-4561-8C65-027012763F31 Q35886326-6D218142-CD0C-4669-BDF7-64D83BE1E1A1 Q37283473-C858637C-7490-451B-B0CD-1BA04C4C88B2 Q38818143-B2EDDCF5-F03C-42ED-9C3E-56E78DC5234E Q38941645-4A936D8C-496B-4252-A853-2C801E660D9D Q39305660-5D5C78F5-A7C3-4461-81A0-B432DFB94B76 Q39406168-90575357-20D7-417B-9ACE-56123E676A01 Q41112245-344A2003-9617-409D-BD12-AC0E746E9679 Q42645380-05469E6E-FEBD-454D-B09D-0F893718E27E Q48718420-A1E74EF4-2F68-4130-A308-3753A859C4BB Q54296578-5DACFB8B-2CF5-4208-8065-A7B717F61F64 Q55407628-DFECC070-2C2D-4F8D-AEE6-1109B2CC3195

P2860

Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.

http://www.wikidata.org/entity/Q34502573

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.

@ast

Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.

@en

Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.

@nl

type

label

Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.

@ast

Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.

@en

Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.

@nl

prefLabel

Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.

@ast

Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.

@en

Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.

@nl

P1433

Q34502573-04260481-AF50-4788-84AF-86C38050A8A6

P1476

Q34502573-D61391BA-870A-48DF-AAB7-8FB67D90BD05

P2093

Q34502573-1AC4417B-F09A-4A6D-9563-F08CEBDF06D5

Q34502573-29D56C4E-D4B3-4C8E-896E-5547F2F6F7E7

Q34502573-5A09F6DF-22C5-4811-A769-5104390EC8FD

Q34502573-800CD83C-0CF4-4E84-9994-E61BF6DE25F1

Q34502573-9811E6F1-8019-44DD-A300-763BDC9AC25A

Q34502573-B0D96DA9-C8F3-47C4-A632-71C4D142C128

Q34502573-C890228E-5D14-4E99-82EB-0E21D19C69E0

Q34502573-D549107E-EE81-4897-AD37-1B0652997D70

P2860

Q34502573-037D559A-3EA1-4B1A-9755-5E4225A28B37

Q34502573-089163C4-D9AC-4796-B5E0-D9874D20486B

Q34502573-09E5A820-698F-4DDE-BC7D-05B25F413FE8

Q34502573-0A1326BB-1E75-4C96-9082-C7F51A35DB7F

Q34502573-1951C8F7-5381-4593-9D16-51EC7E53064C

Q34502573-1A07B5BE-8199-46E3-AA90-923B0C8E30DA

Q34502573-1A74ADAC-2A89-4471-AF7D-2E4C34FA89F2

Q34502573-1E42781D-4796-40A3-9A99-E6EEA4FAB83E

Q34502573-25C04167-789A-4420-BBAB-775B6052AF61

Q34502573-26FBDC6C-6FB5-416A-8CAD-746248844FEC

P304

Q34502573-C73E64A8-EEF9-4959-BE53-C262AE2356DC

P31

Q34502573-AB048F90-0FA8-48B1-9FDD-EC03E137824C

P356

Q34502573-9D4E9282-B2CF-4BA2-9F2F-3E7AC77CBE89

P433

Q34502573-2C8F40A4-3886-49EB-A169-66221AC505CD

P478

Q34502573-25FCC5CC-8F8A-45DD-AA05-5D7FE0C7555B

P50

Q34502573-1F512F9B-B35F-4638-B77C-3E349C7FA7A9

Q34502573-3CEFE1B6-706F-4536-A16A-8E55BC21A456

Q34502573-5D58FF89-7614-4B9A-BBB9-6D125041A069

Q34502573-68DCDEB5-A775-4587-8C8B-A2DAC4437554

Q34502573-945BE548-9370-4CE1-9797-F50C86B229D5

P577

Q34502573-0E9E189C-DA2E-493A-9F1D-7F5A37CDF8CD

P5875

Q34502573-EA156A71-BD64-4A2B-941A-F75EA16A82E8

P698

Q34502573-91DBE3E2-A261-4033-B4FE-93E8E8BBC8BD

P932

Q34502573-AC9B6CA1-07FF-4C8C-881C-D12FADCC00D7

P356

02652048.2013.879932

P1433

Journal of Microencapsulation

P1476

Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.

@en

P2093

Bronwyn Scott

http://www.w3.org/2001/XMLSchema#string

Christian Celia

http://www.w3.org/2001/XMLSchema#string

Haifa Shen

http://www.w3.org/2001/XMLSchema#string

Jianghua Wang

http://www.w3.org/2001/XMLSchema#string

Kathryn Boom

http://www.w3.org/2001/XMLSchema#string

Krishna Suri

http://www.w3.org/2001/XMLSchema#string

Mauro Ferrari

http://www.w3.org/2001/XMLSchema#string

Yi Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential

Osmotically induced shape changes of large unilamellar vesicles measured by dynamic light scattering.

Celastrol suppresses tumor cell growth through targeting an AR-ERG-NF-κB pathway in TMPRSS2/ERG fusion gene expressing prostate cancer

Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system.

In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer.

Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil.

Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaB

Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting.

Toxicity of dimethyl sulfoxide, alone and in combination.

Formulation and evaluation of celastrol-loaded liposomes.

P304

501-507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/02652048.2013.879932

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Roberto Molinaro

Donatella Paolino

Carlotta Borsoi

P577

2014-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261030669

http://www.w3.org/2001/XMLSchema#string

P698

24654943

http://www.w3.org/2001/XMLSchema#string

P932

4230278

http://www.w3.org/2001/XMLSchema#string